MedPath

Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot

Not Applicable
Not yet recruiting
Conditions
Opioid Tapering
Registration Number
NCT07202026
Lead Sponsor
Kaiser Permanente
Brief Summary

Because of recent policies to decrease opioid use, some people using long-term opioid therapy (LTOT) are encouraged or required to stop (discontinue) taking opioids. That has led experts to be concerned that patients whose LTOT is discontinued could have untreated pain, turn to other substance use and possibly illicit opioids, or have worsened mental health symptoms leading to suicide. To guide safer policies, guidelines, and care, this study will interview patients and doctors about discontinuing LTOT and use the results to develop a patient-centered decision aid (DA) to improve patient-provider communication around discontinuation of LTOT. Once the DA is finalized, it will be pilot tested with a group of 30 patients who are currently on LTOT. The pilot will assess DA implementation feasibility; acceptability; knowledge transfer; and ability to successfully foster positive, patient-centered conversations about opioid discontinuation.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Acceptability of DA1-2 weeks

We will use Matlock et al.'s acceptability ranking scale to assess the acceptability of the DA to patients

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kaiser Permanente Washington Health Research Institute

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

Kaiser Permanente Washington Health Research Institute
πŸ‡ΊπŸ‡ΈSeattle, Washington, United States
Sarah J McDonald, MPH
Contact
833-771-0664
sarah.j.mcdonald@kp.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.